Johnson & Johnson (JNJ) Accumulated Expenses (2009 - 2026)

Johnson & Johnson has disclosed Accumulated Expenses across 18 years of filings, most recently posting $7.4 billion for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $7.4 billion, up 190.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 billion (up 190.04% YoY), and the FY2025 annual result was $8.6 billion, up 108.29% from the prior year.
• Accumulated Expenses came in at $7.4 billion for Q1 2026 at Johnson & Johnson, down from $8.6 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $13.0 billion in Q2 2022 to a low of $2.6 billion in Q1 2025.
• The 5-year median for Accumulated Expenses is $7.0 billion (2024), against an average of $7.4 billion.
• Across the five-year window, Accumulated Expenses surged 531.36% in 2022 and tumbled 63.66% in 2025, its largest moves.
• Johnson & Johnson's Accumulated Expenses stood at $12.0 billion in 2022, then plunged by 66.59% to $4.0 billion in 2023, then climbed by 3.33% to $4.1 billion in 2024, then surged by 108.29% to $8.6 billion in 2025, then fell by 13.91% to $7.4 billion in 2026.
• The last three Accumulated Expenses figures came in at $7.4 billion (Q1 2026), $8.6 billion (Q4 2025), and $6.9 billion (Q3 2025), per Business Quant data.